Library / regulatory-reference
Colombia: National Institute for Food and Drug Surveillance (INVIMA)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The National Institute for Food and Drug Surveillance, known as INVIMA, is Colombia's national regulator for medicines, biological products, medical devices, food, cosmetics and household products, a scientific-technical institute under the Ministry of Health.
Colombia is one of Latin America's larger pharmaceutical markets, and INVIMA is among the region's most institutionally developed regulators, with international recognition for the maturity of its medicines oversight.
How products enter the market
Medicines require a sanitary registration granted after evaluation of quality, safety and efficacy, with pharmacological evaluation conducted by a specialized review commission. The institute also licenses manufacturing and import establishments and operates one of the region's stronger pharmacovigilance programs.
Medical devices require registration with risk-based classification, and INVIMA's surveillance mandate extends across its full product portfolio, including food and cosmetics, giving it an unusually wide market-watch role.
Regional and international role
INVIMA is a reference authority within Latin American regulatory cooperation: its assessments are relied upon by neighbors, and it participates actively in international harmonization networks for medicines and devices.
Its pharmacovigilance and vaccine-oversight work is internationally regarded, and Colombia is a common site for internationally sponsored clinical research, which the institute oversees.
Using this profile
INVIMA publishes registers, guidance and safety communications in Spanish through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: INVIMA illustrates the science-led Latin American institute: a technically grounded regulator whose assessments carry reference weight across the region, with a notably broad surveillance remit spanning medicines to food.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.